Elute
Mr. Serbousek joined the Company’s Board in August 2016. He currently serves as the President and Chief Executive Officer of OrthoFix, a global medical device company focused on musculoskeletal products and therapies. He is a seasoned executive with more than 30 years of experience in the medical device and biotech industries, serving in several leadership positions at Biomet Inc., including Worldwide President of Biomet Biologics, Worldwide Group President of Orthopedics, and President of U.S. Orthopedics. Prior to joining Biomet, he held various general management positions within Medtronic Inc. including Worldwide Division President, Spine, Worldwide Vice President, and General Manager of Biologics for their Spine and Biologics business. Additionally, Serbousek spent 13 years with DePuy Orthopedics, a Johnson & Johnson company where he served in numerous roles of increasing responsibility, including the Vice President of Marketing and Product Development and as Vice President of Spinal Operations. Mr. Serbousek holds a B.S. in Engineering from Washington State University and a Masters of Science degree in Bioengineering from the University of Utah, and later completed several advanced management programs including a program at the IMD International School of Management in Lausanne, Switzerland.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Elute
Elute aims to be the leader in developing and commercializing a new class of polymer-controlled drug delivery devices designed to prevent and treat orthopedic and other surgical bone infections.